Treatment strategies for childhood noninfectious chronic uveitis: an update

Bibliography

• Punzi L, Furlan A, Podswiadek M, Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev 2009;8:228-32
   PubMed Web of Science ®Google Scholar
• Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 2010;9:A325-9
   PubMed Web of Science ®Google Scholar
• Lyon F, Gale RP, Lightman S. Recent developments in the treatment of uveitis: an update. Expert Opin Investig Drugs 2009;18:609-16
   PubMed Web of Science ®Google Scholar
• Zierhut M, Doycheva D, Biester S, Therapy of uveitis in children. Int Ophthalmol Clin 2008;48:131-52
   PubMedGoogle Scholar
• Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 2005;32:362-5
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Mingels A, Heinz C, Ganser G. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol 2007;17:743-8
   PubMed Web of Science ®Google Scholar
• Schatz CS, Uzel JL, Leininger L, Immunosuppressants used in a steroid-sparing strategy for childhood uveitis. J Pediatr Ophthalmol Strabismus 2007;44:28-34
   PubMed Web of Science ®Google Scholar
• Budde K, Glander P, Bauer S, Pharmacodynamic monitoring of mycophenolate mofetil. Clin Chem Lab Med 2000;38:1213-16
   PubMed Web of Science ®Google Scholar
• Doycheva DG, Deuter CM, Stuebiger N, Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol 2007;91:180-4
   PubMed Web of Science ®Google Scholar
• Sobrin L, Christen W, Foster CS. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology 2008;115:1416-21
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan CC, Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 1991;112:138-46
   PubMed Web of Science ®Google Scholar
• Feutren G, Mihatsch MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N Engl J Med 1992;326:1654-60
   PubMed Web of Science ®Google Scholar
• Kilmartin DJ, Forrester JV. Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 1998;82:737-42
   PubMed Web of Science ®Google Scholar
• Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 2003;14:395-8
   PubMedGoogle Scholar
• Tappeiner C, Roesel M, Heinz C, Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye 2009;23:1192-8
   PubMed Web of Science ®Google Scholar
• Atzeni F, Sarzi-Puttini P, Doria A, Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. Autoimmun Rev 2005;4:144-52
   PubMed Web of Science ®Google Scholar
• Saurenmann RK, Levin AV, Rose JB, Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford) 2006;45:982-9
   PubMed Web of Science ®Google Scholar
• Ardoin SP, Kredich D, Rabinovich E, Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up. Am J Ophthalmol 2007;144:844-9
   PubMed Web of Science ®Google Scholar
• Simonini G, Zannin ME, Caputo R, Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. Rheumatology (Oxford) 2008;47:1510-14
   PubMed Web of Science ®Google Scholar
• Rajaraman RT, Kimura Y, Li S, Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology 2006;113:308-14
   PubMed Web of Science ®Google Scholar
• Kahn P, Weiss M, Imundo LF, Levy DM. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 2006;113:860-4
   PubMed Web of Science ®Google Scholar
• Imrie FR, Dick AD. Biologics in the treatment of uveitis. Curr Opin Ophthalmol 2007;18:481-6
   PubMed Web of Science ®Google Scholar
• Smith JA, Thompson DJ, Whitcup SM, A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 2005;53:18-23
   PubMed Web of Science ®Google Scholar
• Tynjala P, Lindahl P, Honkanen V, Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 2007;66:548-50
   PubMed Web of Science ®Google Scholar
• Wright T, Cron RQ. Pediatric rheumatology for the adult rheumatologist II: uveitis in juvenile idiopathic arthritis. J Clin Rheumatol 2007;13:205-10
   PubMed Web of Science ®Google Scholar
• Vazquez Cobain LB, Flynn T, Lehman TJA. Adalimumab therapy for childhood uveitis. J Pediatr 2006;149:572-5
   PubMed Web of Science ®Google Scholar
• Biester S, Deute C, Michels H, Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 2007;91:319-24
   PubMed Web of Science ®Google Scholar
• Tynjala P, Kotaniemi K, Lindahl P, Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology 2008;47:339-44
   PubMed Web of Science ®Google Scholar
• Simonini G, Taddio A, Cattalini M, Prevention of flare recurrences in childhood refractory chronic uveitis: an open-label comparative study of Adalimumab versus Infliximab. Arthritis Care Res 2011;63:612-18
   PubMed Web of Science ®Google Scholar
• Sen HN, Levy-Clarke G, Faia LJ, High-dose Daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. Am J Ophthalmol 2009;148:696-703
   PubMed Web of Science ®Google Scholar
• Angeles-Han S, Flynn T, Lehman T. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report. J Rheumatol 2008;35:1897-8
   PubMed Web of Science ®Google Scholar
• Zulian F, Balzarin M, Falcini F, Abatacept in refractory Anti-TNF resistant juvenile idiopathic arthritis-related uveitis. Arthritis Care Res 2010;62:821-5
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Miserocchi E, Heinz C, Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology (Oxford) 2011;50:1390-4
   PubMed Web of Science ®Google Scholar